We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sourcebio International Plc | LSE:SBI | London | Ordinary Share | GB00BKSB1674 | ORD GBP0.0015 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 115.00 | 105.00 | 150.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
09/6/2021 07:28 | You would think so. Unfortunately covid and testing I believe will go on for much longer than we all want, when travel ramps up.... Every new variant seems to have implications for one thing or another. SBI tend to release bits of good news between results so hopefully that continues and the CEO stays away from the camera. | mr euro | |
08/6/2021 21:52 | All the extra testing for new variants should be good for Source. | boonboon | |
28/5/2021 15:37 | Something has happened, I don't know what but its odd to the MM's paying full price and more for stock. | mr euro | |
28/5/2021 13:12 | I think I'd be happy just to get my money back here. Every other stock I own is up. I'm happy to be patient here though. The Boots deal should be of prominence when travel begins seriously. | pngasef | |
28/5/2021 12:20 | MM's wanting stock. | mr euro | |
26/5/2021 15:53 | If he could say i'm sure he would. I think Boots prevented him as part of the deal. | pngasef | |
26/5/2021 12:33 | See Boots is now using Sourcebio Why on earth doesn't Jay LeCoque just say? It's ridiculous. Doesn't he care about his share price? | smithless | |
24/5/2021 09:06 | Not sure investors really appreciate how important ISO 15189 accreditation is for Source. I don't know how up to date UKAS website is, but only a handful of private companies outside the NHS are accredited to take PCR swabs and analyse them for Covid-19. Of those only Oncologia, Nationwide Pathology and SourceBio, from what I can see, are open to the general public to analyse PCR swabs. The hundreds of others who are selling PCR test under the ' Government Approved website' are just taking swabs and sending them to ISO 15189 or ISO17025 (none under this ISO do general public Covid analysis)accredited labs. If travels takes off again Source will be doing tens of thousands of tests per day!!! | smithless | |
21/5/2021 15:11 | SourceBio (7mins 15secs) discussed on today's VOXmarkets videocast www.linkedin.com/pos | brummy_git | |
20/5/2021 15:48 | Better to be lucky than good and nice to cover the spread from my recent purchase! Makes a change! Unfortunately I can see this covid nonsense being around for while yet and by the time it winds down, SBI could have cash to the value of their current market cap :) | mr euro | |
20/5/2021 10:49 | It'd be lovely to see some director buys. | pngasef | |
20/5/2021 07:58 | Marvellous news out today from laboratory services, genomic sequencing & #covid testing firm Sourcebio Plc. All the news & commentary here. www.linkedin.com/pos | brummy_git | |
20/5/2021 07:18 | Two lots of excellent news today: - "successful with its tender for the Lot 4 Framework Agreement under Public Health England's ("PHE") National Microbiology Framework to provide its Clinical Laboratory Diagnostic Testing Services" - "added to the UK Government's approved list as a private provider of day two and day eight ("D2/D8") coronavirus testing for all international arrivals for both SARS-CoV-2 PCR testing and SARS-CoV 2 genome sequencing testing services" | rivaldo | |
19/5/2021 11:49 | Clearly the market doesn't believe Liberum's (house broker) forecasts for 2021 ie Rev £156m, EBIT £54.9m esp 60p as its currently on a forward P/E of 2.6x. I have over estimated PCR tests being done, as the 1m stated in results was cumulative May-Mar 2021. Even if it makes £100m revenue at 25% EBIT margins, it have Y/E cash of around £35m. At the current share price that's an EV/EBIT multiple of 3.2x. Now below IPO price of 162p, so will look to buy more and hopefully management will do likewise. | smithless | |
19/5/2021 08:54 | Which aspect of the fundamentals led you to invest further ? | scruff1 | |
19/5/2021 08:05 | likewise picked up 5000 this morning. | smithless | |
18/5/2021 16:15 | I have put my thought on the CEO to one side and looked at the fundamentals. Given the drop today I had to buy a few more. Bought in 2 lots late this afternoon. | mr euro | |
18/5/2021 08:13 | You may be right smithless. I have been in since the beginning and only recently reduced my holding, I made a bit of money here and still hold some (may add even). I actually had confidence in him at the beginning, but every time he gets in front of the camera my level of trust in him reduces. Yes any CEO has many moving parts and this is a small company, perhaps he needs more support and is spread too thinly. I can believe that narrative. I will get my head in the numbers again and look to add if they look attractive. | mr euro | |
17/5/2021 17:14 | Mr Euro, he did an excellent job at Celsus International, make very good returns for its investors. Very hopeful he'll do the same here. I listened to the AJ Bell interview and although he was a bit nervous, I just think he has many moving parts and he doesn't want to overplay his hand. Just as a reference point an av of 256,000 PCR test per day done over last 7 days. These were just what the government did. Source did 1m tests in Q1 and Q2 looks to be at the same level. | smithless | |
17/5/2021 11:42 | I cant speak on behalf of others but (as I have already stated) I wouldn't trust the CEO as far as I could throw him. All if's, didn't take off as planned, only planning 2k tests a day but we can do up to 5k but don't want to bla bla bla. He's a wide boy. I have reduced my holding to only holding peanuts. | mr euro | |
17/5/2021 10:33 | hxxps://coviduk.sour Tests now available with competitive pricing Why the stock keeps going down ? | andre2499 | |
14/5/2021 13:50 | New presentation by CEO | pob69 | |
12/5/2021 09:24 | I see SBI as another Chris Mills/Harwood vehicle just like EFK Diag etc. I suspect it will make some interesting IP acquisition to justify its IPO multiple | smithless | |
12/5/2021 07:34 | Presentation was supposed to have been recorded and available later in the week via AJ Bell/Shares. Not sure how this will work as newbie to their platform/ | pugugly | |
11/5/2021 20:11 | png - is there a link for that? | supernumerary |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions